Cargando…
Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways
BACKGROUND: Apixaban effectively lowers the risk of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation. Systemic exposure to a given apixaban dose depends on multiple clearance pathways. Though routine quantification of direct oral anticoagulants (DOACs) in neuro...
Autores principales: | Huppertz, Andrea, Grond-Ginsbach, Caspar, Dumschat, Chris, Foerster, Kathrin I., Burhenne, Jürgen, Weiss, Johanna, Czock, David, Purrucker, Jan C., Rizos, Timolaos, Haefeli, Walter E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716843/ https://www.ncbi.nlm.nih.gov/pubmed/31464657 http://dx.doi.org/10.1186/s40360-019-0331-9 |
Ejemplares similares
-
Low Exposure to Direct Oral Anticoagulants Is Associated with Ischemic Stroke and Its Severity
por: Rizos, Timolaos, et al.
Publicado: (2022) -
Preparation of Apixaban Solid Dispersion for the Enhancement of Apixaban Solubility and Permeability
por: Lee, Juseung, et al.
Publicado: (2023) -
Apixaban and oral implications
por: Lopez-Galindo, Monica, et al.
Publicado: (2015) -
Apixaban-Induced Hepatotoxicity
por: Ansari, Umair, et al.
Publicado: (2022) -
Implications of apixaban for dental treatments
por: Curto, Adrian, et al.
Publicado: (2016)